NASDAQ:ICCM IceCure Medical (ICCM) Stock Price, News & Analysis $0.73 +0.03 (+4.21%) Closing price 11/13/2026 04:00 PM EasternExtended Trading$0.73 0.00 (0.00%) As of 11/13/2026 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOwnershipSEC Filings About IceCure Medical Stock (NASDAQ:ICCM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get IceCure Medical alerts:Sign Up Key Stats Today's Range$0.68▼$0.8050-Day Range$0.68▼$2.2352-Week Range$0.65▼$22.50Volume22,270 shsAverage Volume121,151 shsMarket Capitalization$2.50 millionP/E RatioN/ADividend YieldN/APrice Target$30.00Consensus RatingHold Company Overview IceCure Medical Ltd. is an Israel-based medical technology company focused on minimally invasive cryoablation treatments for cancerous and benign tumors. Its technology uses extremely cold temperatures, generated by liquid nitrogen, to destroy targeted tissue while limiting damage to surrounding areas. The company’s primary product is the ProSense Cryoablation System, which consists of a console, cryoprobes and related components. The system is designed to freeze and ablate tumors through a percutaneous procedure, generally under image guidance. IceCure has developed applications for tumors in areas including the breast, kidney, liver and bone. IceCure markets its technology internationally and has pursued regulatory clearances and clinical development in the United States, Europe and other global markets. The company’s products are intended to support less invasive treatment options and, in certain cases, may be used as an alternative or complement to surgery and other cancer therapies.AI Generated. May Contain Errors. Read More IceCure Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks58th Percentile Overall ScoreICCM MarketRank™: 2.89014306339 of 5 starsIceCure Medical scored higher than 58% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingHold Consensus RatingIceCure Medical has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialIceCure Medical has a consensus price target of $30.00, representing about 4,009.6% upside from its current price of $0.73.Amount of Analyst CoverageIceCure Medical has only been the subject of 2 research reports in the past 90 days.Read more about IceCure Medical's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for IceCure Medical are expected to grow in the coming year, from ($4.61) to ($3.61) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of IceCure Medical is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of IceCure Medical is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIceCure Medical has a P/B Ratio of 0.20. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about IceCure Medical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.68% of the float of IceCure Medical has been sold short.Short Interest Ratio / Days to CoverIceCure Medical has a short interest ratio ("days to cover") of 0.61, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IceCure Medical has recently increased by 33.07%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIceCure Medical does not currently pay a dividend.Dividend GrowthIceCure Medical does not have a long track record of dividend growth. News and Social Media2.9 / 5News Sentiment0.61 News SentimentIceCure Medical has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for IceCure Medical this week, compared to 3 articles on an average week.Search Interest1 people have searched for ICCM on MarketBeat in the last 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, IceCure Medical insiders have not sold or bought any company stock.Percentage Held by Insiders2.44% of the stock of IceCure Medical is held by insiders.Percentage Held by Institutions0.62% of the stock of IceCure Medical is held by institutions.Read more about IceCure Medical's insider trading history. Receive ICCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IceCure Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ICCM Stock News HeadlinesIceCure Medical to Report Third Quarter 2026 Financial and Operating Results on November 18, 2026November 11, 2026 | prnewswire.comIceCure Medical Secures New Chinese Patent for Cryogenic Technology ConnectorNovember 9, 2026 | finance.yahoo.comI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.November 15 at 1:00 AM | Behind the Markets (Ad)IceCure Granted New Patent in China for Its Cryogenic System Connector, Expanding Its Global IP PortfolioNovember 9, 2026 | prnewswire.comIceCure Medical Shareholders Approve Agenda After Quorum DelayNovember 2, 2026 | tipranks.comIceCure Medical: IceCure Successfully Completes First Cryoablation Treatment in Its ChoICE Post-Marketing Study for Breast Cancer CryoablationOctober 27, 2026 | finanznachrichten.deIceCure Successfully Completes First Cryoablation Treatment in Its ChoICE Post-Marketing Study for Breast Cancer CryoablationOctober 27, 2026 | prnewswire.comIceCure Medical: IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense Breast Cancer Cryoablation at Two U.S. SitesOctober 20, 2026 | finanznachrichten.deSee More Headlines ICCM Stock Analysis - Frequently Asked Questions How have ICCM shares performed this year? IceCure Medical's stock was trading at $18.3030 at the start of the year. Since then, ICCM shares have decreased by 96.0% and is now trading at $0.73. How were IceCure Medical's earnings last quarter? IceCure Medical Ltd. (NASDAQ:ICCM) announced its earnings results on Tuesday, May, 12th. The company reported ($0.06) earnings per share for the quarter, missing analysts' consensus estimates of ($0.03) by $0.03. The business earned $911 thousand during the quarter, compared to the consensus estimate of $1.34 million. IceCure Medical had a negative trailing twelve-month return on equity of 174.26% and a negative net margin of 427.67%. Read the conference call transcript. When did IceCure Medical's stock split? IceCure Medical shares reverse split on Thursday, June 4th 2026.A 1-30 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 3rd 2026. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. When did IceCure Medical IPO? IceCure Medical (ICCM) raised $0 in an initial public offering on Thursday, August 26th 2021. The company issued 4,485,000 shares at $0.00 per share. How do I buy shares of IceCure Medical? Shares of ICCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of IceCure Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that IceCure Medical investors own include Applied Digital (APLD), Alliance Resource Partners (ARLP), CoreWeave (CRWV), Fluence Energy (FLNC), Longeveron (LGVN), Athira Pharma (LONA) and Netflix (NFLX). Company Calendar Today11/15/2026Next Earnings (Estimated)11/18/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 ICCM's financial health is in the Red zone, according to TradeSmith. ICCM has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:ICCM CIK1584371 Webwww.icecure-medical.com Phone972-4623-0333Fax972-4623-0222Employees68Year Founded2006Price Target and Rating Average Price Target for IceCure Medical$30.00 High Price Target$30.00 Low Price Target$30.00 Potential Upside/Downside+4,009.6%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($8.52) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$15.06 million Net Margins-427.67% Pretax MarginN/A Return on Equity-174.26% Return on Assets-112.58% Debt Debt-to-Equity RatioN/A Current Ratio2.88 Quick Ratio2.44 Sales & Book Value Annual Sales$3.38 million Price / Sales0.74 Cash FlowN/A Price / Cash FlowN/A Book Value$3.72 per share Price / Book0.20Miscellaneous Outstanding Shares3,430,000Free Float3,342,000Market Cap$2.50 million OptionableNot Optionable Beta0.57 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:ICCM) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredUnbelievable…Congress is About to Do What?Jim Rickards, former advisor to the CIA, the Pentagon and the White House, says a key turning point in Washing...Paradigm Press | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IceCure Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share IceCure Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.